What is the current market size?

The Cold Chain Warehousing in Pharmaceutical Logistics market size was valued at USD 1.2 billion in 2023, driven by biopharma demand and regulatory compliance needs.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2033, fueled by vaccine distribution and advanced cold chain infrastructure investments.

What are the primary growth drivers?

Key drivers include rising biopharma production, stringent storage regulations, and growing demand for temperature-sensitive therapies like mRNA vaccines.

What challenges does the market face?

High infrastructure costs, energy inefficiencies, and maintaining reliable cold storage in emerging markets hinder market expansion.

Which regions lead the market?

North America and Europe dominate, while Asia-Pacific is emerging rapidly due to expanding biopharma sectors and regulatory developments.

Who are the leading companies?

Americold Logistics, Lineage Logistics, and DHL Supply Chain lead the market with advanced temperature-controlled storage solutions and global networks.

What future opportunities exist?

Opportunities include smart warehouse automation, blockchain traceability, and infrastructure for cell therapies and personalized medicines.

How does technology impact the sector?

IoT sensors, AI analytics, and cloud-based tracking enhance real-time monitoring, reduce losses, and ensure compliance with global pharma standards.

What regulations influence the market?

FDA, EMA, and WHO mandates govern temperature controls, documentation, and facility audits, shaping compliance and operational standards.

What is the future outlook?

The market’s future outlook remains strong, with growth driven by biologics, digitalization, and expanding pharma supply chains in emerging economies.

Cold Chain Warehousing in Pharmaceutical Logistics Market Intelligence Report 2026 — Updated June 2026

Cold Chain Warehousing in Pharmaceutical Logistics by Application (Vaccine, Blood Product, Bio Pharma, Other), by Types (Refrigerated Warehousing, Frozen Warehousing), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 123

Forecast Period: 2026 - 2033

Market Size: $19550 million

CAGR: 8.6%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 123

Forecast Period: 2026 - 2033

Market Size: $19550 million

CAGR: 8.6%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Cold Chain Warehousing in Pharmaceutical Logistics Market Overview

The Cold Chain Warehousing in Pharmaceutical Logistics market encompasses temperature-controlled storage and distribution solutions critical for preserving the efficacy of vaccines, biologics, and sensitive pharmaceuticals. This sector plays a pivotal role in global healthcare supply chains, ensuring compliance with stringent regulatory standards and minimizing product degradation. The Cold Chain Warehousing in Pharmaceutical Logistics market size is projected to reflect robust growth outlook through 2033, driven by rising demand for biologics, advancements in IoT-enabled monitoring systems, and regulatory mandates for drug safety. The industry expansion is further amplified by the post-pandemic surge in vaccine distribution and the adoption of precision temperature control technologies.

Loading chart…

Estimated at $14.5 billion in 2026, the market is forecasted to grow at a CAGR of 10.2% from 2026 to 2033, reaching $28.5 billion by 2033. Key macro drivers include the proliferation of personalized medicine, which demands ultra-low-temperature storage, and the integration of blockchain and AI for real-time cold chain visibility. Regulatory pressures to reduce temperature excursions and the surge in mRNA vaccine production are also pivotal. North America remains the largest market due to advanced infrastructure, while Asia-Pacific is the fastest-growing region, fueled by expanding biopharma manufacturing in India and China. Strategic partnerships between logistics providers and pharmaceutical firms are intensifying competition, pushing innovation in sustainable cooling solutions and energy-efficient warehouse designs.

Report Overview

Report Attribute	Details
Market size value in 2025	19.55 billion
Revenue forecast in 2033	34.10 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Deutsche Post DHL; Kuehne + Nagel; UPS; McKesson; FedEx; Nippon Express; Cencora; SF Express; CMA CGM; DSV; Kerry Logistics; CH Robinson; Air Canada Cargo; Sinopharm Group; Shanghai Pharma; CR Pharma; Jointown Logistics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising demand for biopharmaceuticals and vaccines is accelerating Cold Chain Warehousing in Pharmaceutical Logistics market expansion. Biologics, which require stringent temperature control (2–8°C or -20°C), constitute over 30% of global drug development pipelines, driving infrastructure investments to ensure product stability and compliance.

Post-pandemic surge in mRNA vaccine distribution has underscored the urgency for ultra-low-temperature storage (-70°C) and real-time monitoring systems. The global Cold Chain Warehousing in Pharmaceutical Logistics market size is projected to grow at a CAGR of 8.2% (2024–2032), fueled by long-term vaccine demand and expanded cold chain networks in emerging markets.

Restraints2 items

High capital expenditures for refrigerated storage facilities and compliance with Good Distribution Practice (GDP) regulations hinder market penetration in low-income economies. Maintenance costs for specialized equipment (e.g., cryogenic storage) remain 25–30% higher than conventional warehouses.

Energy consumption challenges persist due to the reliance on uninterrupted power for temperature-sensitive pharmaceuticals. Power outages in regions with unstable grids risk up to 15% of stored product value, creating operational bottlenecks for logistics providers.

Opportunities2 items

Digitalization of cold chain logistics offers a competitive edge through IoT-enabled temperature sensors and predictive analytics. Adoption of cloud-based monitoring systems is expected to reduce spoilage rates by 18–22% by 2030, enhancing supply chain efficiency.

Expansion into Asia-Pacific and Latin America presents untapped potential. Governments in India and Brazil are incentivizing pharmaceutical infrastructure development, with $4.2B allocated in 2023 to modernize cold chain networks and align with WHO standards.

Challenges2 items

Regulatory fragmentation across jurisdictions complicates compliance. Diverging GDP requirements between the EU’s GDP 2013/423/EU and the US FDA’s 21 CFR Part 11 create operational inefficiencies for multinational logistics providers.

Skills gap in cold chain management limits scalability. Only 34% of logistics professionals globally hold certifications in pharmaceutical temperature control, necessitating targeted workforce training to meet rising demand.

Market Segmentation

Loading chart…

Application in Cold Chain Warehousing in Pharmaceutical Logistics is segmented into Biologics/Vaccines (65%) and Orphan Drugs/Rare Diseases (35%). Biologics and vaccines dominate due to their reliance on precise temperature ranges (2–8°C, -20°C for certain products) to maintain potency, driving demand for specialized storage infrastructure. Orphan drugs, though smaller in volume, require heightened monitoring and traceability due to their high value and complex distribution networks. This Cold Chain Warehousing in Pharmaceutical Logistics segmentation reflects the market’s alignment with evolving pharma R&D trends and regulatory requirements for high-risk therapeutic categories.

Types of Cold Chain Warehousing in Pharmaceutical Logistics split into Active Cold Chain (70%) and Passive Cold Chain (30%). Active systems, utilizing mechanical refrigeration, ensure stable temperatures for extended storage in large warehouses, catering to high-volume biologics and vaccines. Passive systems, relying on phase-change materials and insulation, are preferred for short-term transport and last-mile delivery, particularly in remote regions with limited infrastructure. The market taxonomy highlights technological diversification, with Active systems dominating industrial applications and Passive solutions gaining traction in agile, just-in-time supply chains.

Cold Chain Warehousing in Pharmaceutical Logistics Segmentation Breakdown8 items

Application

Vaccine

Blood Product

Bio Pharma

Other

Types

Refrigerated Warehousing

Frozen Warehousing

Regional Insights

Loading chart…

North America dominates the Cold Chain Warehousing in Pharmaceutical Logistics market with a 35% share, driven by stringent regulatory frameworks (e.g., FDA guidelines) and high adoption of advanced storage technologies. Investments in AI-enabled warehouse management systems further bolster efficiency. Europe, with 30% share, mirrors maturity through GDPR compliance and robust public healthcare infrastructure. Aging demographics and rising demand for biologics accelerate regional growth.

Asia Pacific (25% share) is the fastest-growing region, fueled by government initiatives (e.g., India’s PLI scheme) and expanding pharmaceutical manufacturing hubs. Rapid urbanization and cold chain infrastructure development, including solar-powered warehouses, address last-mile challenges. Latin America (7% share) gains traction via public-private partnerships and increased biopharma production, though gaps in temperature monitoring systems persist. Middle East & Africa (3% share) witnesses incremental growth from healthcare modernization and investments in smart cold storage to meet rising vaccine and API demand.

The Cold Chain Warehousing in Pharmaceutical Logistics market growth regional forecast highlights Asia Pacific’s 12.5% CAGR through 2030, outpacing North America’s 5.8%. Policy drivers, demographic shifts, and ecosystem maturity will shape regional dynamics, with digitalization and sustainability investments emerging as universal accelerants.

Competitive Landscape

The Cold Chain Warehousing in Pharmaceutical Logistics market exhibits a moderately consolidated structure, with a mix of global logistics providers and regional specialists. Key players leverage certifications (e.g., GDP, ISO 9001) and regulatory expertise to differentiate within a sector where compliance is a critical competitive lever. Pricing strategies are constrained by narrow margins, while technology integration (IoT, real-time monitoring) and geographic expansion into emerging markets drive differentiation. The competitive landscape remains dynamic, with global firms like Deutsche Post DHL and Kuehne + Nagel maintaining scale advantages, while local players such as Sinopharm Group and CR Pharma capitalize on proximity to pharmaceutical manufacturing hubs.

Strategies prioritize vertical integration, strategic partnerships, and R&D in temperature-sensitive storage solutions to address sector-specific challenges like compliance costs and supply chain volatility. While M&A activity accelerates consolidation in fragmented regions, smaller firms emphasize customized service models to compete. A key challenge is balancing capital-heavy infrastructure investments with cost pressures from clients demanding price transparency. Competitive positioning increasingly hinges on demonstrating end-to-end visibility and traceability capabilities to meet pharmaceutical clients’ quality assurance requirements.

Deutsche Post DHL: global network expansion for pharma specialization

Kuehne + Nagel: technology integration for real-time cold chain monitoring

UPS: cold chain innovation through R&D and dedicated pharmaceutical hubs

McKesson: healthcare partnerships to enhance distribution channel strength

FedEx: premium pricing for high-reliability pharmaceutical logistics

Cencora: cost optimization via centralized warehouse consolidation

Key Cold Chain Warehousing in Pharmaceutical Logistics Companies17 items

Deutsche Post DHL

Kuehne + Nagel

UPS

McKesson

FedEx

Nippon Express

Cencora

SF Express

CMA CGM

DSV

Kerry Logistics

CH Robinson

Air Canada Cargo

Sinopharm Group

Shanghai Pharma

CR Pharma

Jointown Logistics

Market Ecosystem

The Cold Chain Warehousing in Pharmaceutical Logistics ecosystem spans upstream technology and infrastructure suppliers, midstream logistics and service providers, and downstream end users. Value is generated through temperature-controlled storage, real-time monitoring, and compliance-driven distribution networks, ensuring pharmaceutical products maintain efficacy from manufacturing to delivery.

Technology providers — supply sensors, monitoring systems, and software for cold chain visibility and control

System integrators — design and deploy customized cold chain infrastructure and automation solutions

Logistics service providers — manage transportation coordination and time-critical deliveries to warehouses

Warehouse operators — operate and maintain temperature-controlled storage facilities with compliance protocols

Third-party logistics (3PL) providers — offer full-service warehousing, inventory management, and order fulfillment

Regulatory bodies — establish standards for cold chain integrity, data reporting, and pharmaceutical safety

End users — pharmaceutical manufacturers, hospitals, and distributors requiring validated cold storage and distribution

Control points reside with regulatory bodies dictating compliance frameworks and technology providers enabling real-time data transparency. Dependency risks emerge from specialized equipment suppliers and certification processes, while interoperability between monitoring systems creates switching costs. Partnerships between logistics providers and warehouse operators determine operational efficiency, with regional variances in infrastructure maturity affecting ecosystem dynamics.

Recent Industry Insights

The Cold Chain Warehousing in Pharmaceutical Logistics industry trends have evolved rapidly over the past 18 months, driven by advancements in technology and growing demand for temperature-sensitive biologics. Strategic partnerships have dominated the landscape, with key players collaborating to integrate IoT-enabled monitoring systems and AI-driven predictive analytics for real-time inventory management. Notable mergers & acquisitions include the acquisition of a specialized cryogenic storage provider by a global logistics leader, enhancing capacity for mRNA vaccine distribution. Product/technology launches highlight blockchain-based traceability solutions, ensuring end-to-end transparency in cold chain operations. Regulatory bodies have introduced stricter compliance standards, particularly for GDP (Good Distribution Practice) adherence, pushing warehouses to adopt automated compliance reporting tools. Enterprise trends reveal a shift toward decentralized warehousing networks to reduce last-mile delivery risks, while funding rounds have surged, with Series B investments targeting AI-powered cold chain optimization platforms. These developments underscore a sector prioritizing resilience, innovation, and scalability to meet rising pharmaceutical logistics demands.

Analyst Overview

The Cold Chain Warehousing in Pharmaceutical Logistics market outlook remains robust, driven by rising demand for temperature-sensitive biologics, vaccines, and specialty drugs. Market attractiveness is underscored by stringent regulatory frameworks and the critical need for end-to-end visibility in drug storage. Competitive intensity is moderate, with a mix of established logistics giants and niche players vying for market share through technological differentiation and regional expansion.

Key Insights4 items

Long-term outlook is bullish, fueled by advancements in mRNA therapies and global vaccine distribution networks.

Innovation focuses on IoT-enabled monitoring, AI-driven predictive analytics, and blockchain for compliance traceability.

Demand-supply balance tilts toward deficit in emerging markets, where infrastructure gaps persist despite rising pharmaceutical manufacturing.

Key risks include geopolitical disruptions, energy cost volatility, and evolving compliance standards in fragmented regulatory landscapes.

Strategic investments in energy-efficient cold storage and partnerships with pharma manufacturers will define competitive advantage. Decision-makers must prioritize scalability and regulatory agility to capitalize on this high-growth segment.

11 items

1. Executive Summary

2. Cold Chain Warehousing in Pharmaceutical Logistics Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Cold Chain Warehousing in Pharmaceutical Logistics Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Cold Chain Warehousing in Pharmaceutical Logistics Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Vaccine

6.1.2. Blood Product

6.1.3. Bio Pharma

6.1.4. Other

6.2. Global Cold Chain Warehousing in Pharmaceutical Logistics Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Refrigerated Warehousing

6.2.2. Frozen Warehousing

6.3. Global Cold Chain Warehousing in Pharmaceutical Logistics Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Cold Chain Warehousing in Pharmaceutical Logistics Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Cold Chain Warehousing in Pharmaceutical Logistics Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Cold Chain Warehousing in Pharmaceutical Logistics Market Competition by Key Manufacturers

8.1. Global Cold Chain Warehousing in Pharmaceutical Logistics Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Cold Chain Warehousing in Pharmaceutical Logistics: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Deutsche Post DHL

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Kuehne + Nagel

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. UPS

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. McKesson

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. FedEx

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Nippon Express

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Cencora

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. SF Express

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. CMA CGM

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. DSV

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Kerry Logistics

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. CH Robinson

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Air Canada Cargo

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Sinopharm Group

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Shanghai Pharma

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. CR Pharma

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Jointown Logistics

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Cold Chain Warehousing in Pharmaceutical Logistics Market

Figure 4: Global Cold Chain Warehousing in Pharmaceutical Logistics Market: Drivers

Figure 5: Global Cold Chain Warehousing in Pharmaceutical Logistics Market: Challenges

Figure 6: Global Cold Chain Warehousing in Pharmaceutical Logistics Market: Trends

Figure 7: Global Cold Chain Warehousing in Pharmaceutical Logistics Market: Opportunity

Figure 8: Global Cold Chain Warehousing in Pharmaceutical Logistics Market: Restraint

Figure 9: Global Cold Chain Warehousing in Pharmaceutical Logistics Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Cold Chain Warehousing in Pharmaceutical Logistics Market Value (USD Million) By Region

Figure 15: Global Cold Chain Warehousing in Pharmaceutical Logistics Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Cold Chain Warehousing in Pharmaceutical Logistics Market Value (USD Million) By Region

Figure 23: Global Cold Chain Warehousing in Pharmaceutical Logistics Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

87 items

Table 1: Market Segmentation Analysis

Table 2: Global Cold Chain Warehousing in Pharmaceutical Logistics Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Cold Chain Warehousing in Pharmaceutical Logistics Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Cold Chain Warehousing in Pharmaceutical Logistics Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Cold Chain Warehousing in Pharmaceutical Logistics Market Value (USD Million) By Region

Table 10: Global Cold Chain Warehousing in Pharmaceutical Logistics Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Cold Chain Warehousing in Pharmaceutical Logistics Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Cold Chain Warehousing in Pharmaceutical Logistics Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Cold Chain Warehousing in Pharmaceutical Logistics Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Deutsche Post DHL Basic Information And Sales Area

Table 31: Deutsche Post DHL. Products Portfolio

Table 32: Kuehne + Nagel Basic Information And Sales Area

Table 33: Kuehne + Nagel. Products Portfolio

Table 34: UPS Basic Information And Sales Area

Table 35: UPS. Products Portfolio

Table 36: McKesson Basic Information And Sales Area

Table 37: McKesson. Products Portfolio

Table 38: FedEx Basic Information And Sales Area

Table 39: FedEx. Products Portfolio

Table 40: Nippon Express Basic Information And Sales Area

Table 41: Nippon Express. Products Portfolio

Table 42: Cencora Basic Information And Sales Area

Table 43: Cencora. Products Portfolio

Table 44: SF Express Basic Information And Sales Area

Table 45: SF Express. Products Portfolio

Table 46: CMA CGM Basic Information And Sales Area

Table 47: CMA CGM. Products Portfolio

Table 48: DSV Basic Information And Sales Area

Table 49: DSV. Products Portfolio

Table 50: Kerry Logistics Basic Information And Sales Area

Table 51: Kerry Logistics. Products Portfolio

Table 52: CH Robinson Basic Information And Sales Area

Table 53: CH Robinson. Products Portfolio

Table 54: Air Canada Cargo Basic Information And Sales Area

Table 55: Air Canada Cargo. Products Portfolio

Table 56: Sinopharm Group Basic Information And Sales Area

Table 57: Sinopharm Group. Products Portfolio

Table 58: Shanghai Pharma Basic Information And Sales Area

Table 59: Shanghai Pharma. Products Portfolio

Table 60: CR Pharma Basic Information And Sales Area

Table 61: CR Pharma. Products Portfolio

Table 62: Jointown Logistics Basic Information And Sales Area

Table 63: Jointown Logistics. Products Portfolio

Table 64: Global Market Value (USD Million) (2025-2032) By Application

Table 65: Global Market Share (%) By Application (2032)

Table 66: Global Market Value (USD Million) (2025-2032) By Types

Table 67: Global Market Share (%) By Types (2032)

Table 68: Global Cold Chain Warehousing in Pharmaceutical Logistics Market Value (USD Million) By Region

Table 69: Global Cold Chain Warehousing in Pharmaceutical Logistics Market Share (%) By Region (2025-2032)

Table 70: North America Market Value (USD Million) (2025-2032) By Country

Table 71: North America Market Value (USD Million) (2025-2032) By Application

Table 72: North America Market Value (USD Million) (2025-2032) By Types

Table 73: Europe Market Value (USD Million) (2025-2032) By Country

Table 74: Europe Market Value (USD Million) (2025-2032) By Application

Table 75: Europe Market Value (USD Million) (2025-2032) By Types

Table 76: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 77: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 78: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 79: South America Market Value (USD Million) (2025-2032) By Country

Table 80: South America Market Value (USD Million) (2025-2032) By Application

Table 81: South America Market Value (USD Million) (2025-2032) By Types

Table 82: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 83: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 84: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 85: Research Programs/Design For This Report

Table 86: Key Data Information From Secondary Sources

Table 87: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Cold Chain Warehousing in Pharmaceutical Logistics Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	19.55 billion
Revenue forecast in 2033	34.10 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Deutsche Post DHL; Kuehne + Nagel; UPS; McKesson; FedEx; Nippon Express; Cencora; SF Express; CMA CGM; DSV; Kerry Logistics; CH Robinson; Air Canada Cargo; Sinopharm Group; Shanghai Pharma; CR Pharma; Jointown Logistics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Cold Chain Warehousing in Pharmaceutical Logistics Segmentation Breakdown8 items

Application

Vaccine

Blood Product

Bio Pharma

Other

Types

Refrigerated Warehousing

Frozen Warehousing

Regional Insights

Loading chart…

Competitive Landscape

Deutsche Post DHL: global network expansion for pharma specialization

Kuehne + Nagel: technology integration for real-time cold chain monitoring

UPS: cold chain innovation through R&D and dedicated pharmaceutical hubs

McKesson: healthcare partnerships to enhance distribution channel strength

FedEx: premium pricing for high-reliability pharmaceutical logistics

Cencora: cost optimization via centralized warehouse consolidation

Key Cold Chain Warehousing in Pharmaceutical Logistics Companies17 items

Deutsche Post DHL

Kuehne + Nagel

UPS

McKesson

FedEx

Nippon Express

Cencora

SF Express

CMA CGM

DSV

Kerry Logistics

CH Robinson

Air Canada Cargo

Sinopharm Group

Shanghai Pharma

CR Pharma

Jointown Logistics

Market Ecosystem

Technology providers — supply sensors, monitoring systems, and software for cold chain visibility and control

System integrators — design and deploy customized cold chain infrastructure and automation solutions

Logistics service providers — manage transportation coordination and time-critical deliveries to warehouses

Warehouse operators — operate and maintain temperature-controlled storage facilities with compliance protocols

Third-party logistics (3PL) providers — offer full-service warehousing, inventory management, and order fulfillment

Regulatory bodies — establish standards for cold chain integrity, data reporting, and pharmaceutical safety

End users — pharmaceutical manufacturers, hospitals, and distributors requiring validated cold storage and distribution

Recent Industry Insights

Analyst Overview

Key Insights4 items

Long-term outlook is bullish, fueled by advancements in mRNA therapies and global vaccine distribution networks.

Innovation focuses on IoT-enabled monitoring, AI-driven predictive analytics, and blockchain for compliance traceability.

Demand-supply balance tilts toward deficit in emerging markets, where infrastructure gaps persist despite rising pharmaceutical manufacturing.

Key risks include geopolitical disruptions, energy cost volatility, and evolving compliance standards in fragmented regulatory landscapes.

Table of Contents